Cadence Capital Management Portfolio holdings

Cadence Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Cadence Capital Management held 697 positions worth $2.09B, down 12% from $2.37B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

Cadence Capital Management withdrew a net $380M in Q2 2014, closing 150 positions and reducing 358 holdings. Its most notable exit was Alnylam Pharmaceuticals, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Industrials and Technology.

Against the trend, Cadence Capital Management opened a new position in US Bancorp worth $12.1M.

• Cadence Capital Management's largest Q2 2014 buy was US Bancorp: 279,044 shares worth $12.1M.
• Cadence Capital Management added most to Wynn Resorts in Q2 2014, an estimated $7.23M increase.
• Cadence Capital Management's biggest Q2 2014 reduction was Apple, cutting an estimated $17.7M.
• Cadence Capital Management fully exited Alnylam Pharmaceuticals in Q2 2014, selling an estimated $10.7M.
• Cadence Capital Management's ten largest holdings make up 8.3% of its $2.09B portfolio in Q2 2014.
• Cadence Capital Management opened 113 new positions and closed 150 in Q2 2014.
• Cadence Capital Management's portfolio value fell 12% quarter-over-quarter to $2.09B.

Based on Cadence Capital Management's 13F filing for Q2 2014, filed 23 Jul 2014.